Skip to content

Clinical trials

Muscle Spasticity trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Muscle Spasticity Country / region: United States Clear all

161 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20014
20026
20037
20042
20051
20064
20077
20083
20094
20103
20113
201211
201310
201410
20155
20164
20173
201811
20196
20206
20216
202212
20235
202410
20254
202612

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed89
Recruiting24
Terminated18
Unknown status11
Active, not recruiting10
Withdrawn4
Not yet recruiting3
Suspended1
No longer available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Allergan11
Shirley Ryan AbilityLab7
Vanderbilt University7
Kessler Foundation5
National Institute of Neurological Disorders and Stroke (NINDS)5
Acorda Therapeutics4
Ipsen4
Medical University of South Carolina4
Shepherd Center, Atlanta GA4
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Muscle Spasticity161
Stroke41
Cerebral Palsy33
Spinal Cord Injuries29
Multiple Sclerosis26
Muscle Hypertonia9
Hemiplegia8
Motor Neuron Disease8
Dystonia7
Neurologic Manifestations6

Trials

Showing 26 to 50 of 161. Each trial links to its page on Pharma Observatory.

61 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.